King, Acura in partnership for developing pain treatments

Chain Drug Review, Nov 19, 2007

King Pharmaceuticals Inc. has entered into an agreement with Acura Pharmaceuticals Inc. to develop painkillers using the latter's Aversion technology. King will make an up-front cash payment to Acura of $30 million. King could be responsible for $28 million in additional payments to Acura pending achievement of certain milestones.

COPYRIGHT 2007 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale